ASO Author Reflections:Improving the Quality of Life of Patients with Indeterminate Thyroid Nodules Receiving Molecular Testing - PubMed (original) (raw)

Comment

. 2021 Dec;28(13):8882-8883.

doi: 10.1245/s10434-021-10398-z. Epub 2021 Jul 2.

Affiliations

Comment

ASO Author Reflections:Improving the Quality of Life of Patients with Indeterminate Thyroid Nodules Receiving Molecular Testing

Max A Schumm et al. Ann Surg Oncol. 2021 Dec.

No abstract available

PubMed Disclaimer

Comment on

References

    1. Applewhite MK, James BC, Kaplan SP, et al. Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg. 2016;40(3):551–61. https://doi.org/10.1007/s00268-015-3300-5 . -DOI -PubMed
    1. Wong CW, Schumm MA, Zhu CY, et al. Quality of life following molecular marker testing for indeterminate thyroid nodules. Endocr Pract. 2020. https://doi.org/10.4158/EP-2020-0101 . -DOI -PubMed
    1. Schumm MA, Nguyen DT, Kim J, et al. Longitudinal assessment of quality of life following molecular testing for indeterminate thyroid nodules. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10375-6 .
    1. Marti JL, Shaha AR. Molecular testing for indeterminate thyroid nodules: when the rubber meets the road. JAMA Otolaryngol Head Neck Surg. 2019;145(9):792–3. https://doi.org/10.1001/jamaoto.2019.1465 . -DOI -PubMed

Publication types

MeSH terms

LinkOut - more resources